Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Morepen Laboratories has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major.
Supplies under the mandate are expected to commence within the next 4–5 months, with execution scheduled through Q1 of the following financial year, subject to customary operational and regulatory processes.
This engagement marks one of the most significant single CDMO mandates in the Company’s history, as it scales its global manufacturing footprint.
At 10.49 am, Morepen Laboratories was trading at Rs. 44.44, up by 13.05%, with a volume of 34.84 lakh shares on the BSE.
Patel Engineering has been declare as lowest bidder by HPPCL
23 Feb 2026, 3:00PMLTIMindtree announces multi-year, $100 million strategic agreement with a MedTech company in Europe
23 Feb 2026, 2:52PML&T wins order for Power Transmission & Distribution Business in Saudi Arabia
29-10-2025 10:13:15The ePlane Company signs MOU with Ramco Systems
27-10-2025 12:42:39Refex Industries gets an order worth Rs. 300 Cr from a mining entity in Jharkhand
24-10-2025 13:57:18Diwali Stocks Picks 2025
